CDKN2B-AS1 and non-small cell lung carcinoma: NEAT1 and ANRIL, which are associated with cholesterol synthesis and MI, respectively, were suggested to be biomarkers that identify non-small cell lung carcinoma (NSCLC) (Yu X. et al., 2017; Osielska and Jagodziński, 2018).